These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35246120)

  • 1. Increased serum LOXL2 concentration in pelvic inflammatory disease with pelvic adhesion.
    Xie C; Tang B; Wu K; Meng Q; Wang F
    BMC Womens Health; 2022 Mar; 22(1):59. PubMed ID: 35246120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated exosomal lysyl oxidase like 2 is a potential biomarker for head and neck squamous cell carcinoma.
    Sanada T; Islam A; Kaminota T; Kirino Y; Tanimoto R; Yoshimitsu H; Yano H; Mizuno Y; Okada M; Mitani S; Ugumori T; Tanaka J; Hato N
    Laryngoscope; 2020 May; 130(5):E327-E334. PubMed ID: 31219623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of N-glycosylation by glucosamine hydrochloride inhibits TGF-β1-induced LOXL2 secretion.
    Kamiya T; Kadowaki M; Atobe T; Kunieda K; Morimoto K; Hara H
    J Cell Biochem; 2023 Jun; 124(6):797-807. PubMed ID: 37062903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of lysyl oxidase and lysyl oxidase-like protein 2 suppressed the migration and invasion of trophoblasts by activating the TGF-β/collagen pathway in preeclampsia.
    Xu XH; Jia Y; Zhou X; Xie D; Huang X; Jia L; Zhou Q; Zheng Q; Zhou X; Wang K; Jin LP
    Exp Mol Med; 2019 Feb; 51(2):1-12. PubMed ID: 30804321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased serum lysyl oxidase-like 2 levels correlate with the degree of left atrial fibrosis in patients with atrial fibrillation.
    Zhao Y; Tang K; Tianbao X; Wang J; Yang J; Li D
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29089463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysyl oxidase-like protein 2 (LOXL2) modulates barrier function in cholangiocytes in cholestasis.
    Pollheimer MJ; Racedo S; Mikels-Vigdal A; Marshall D; Bowlus C; Lackner C; Madl T; Karlsen TH; Hov JR; Lyman SK; Adamkewicz J; Smith V; Moreau E; Zollner G; Eide TJ; Stojakovic T; Scharnagl H; Gruber HJ; Stauber RE; Trauner M; Fickert P
    J Hepatol; 2018 Aug; 69(2):368-377. PubMed ID: 29709678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysyl oxidase-like-2 (LOXL2) is a major isoform in chondrocytes and is critically required for differentiation.
    Iftikhar M; Hurtado P; Bais MV; Wigner N; Stephens DN; Gerstenfeld LC; Trackman PC
    J Biol Chem; 2011 Jan; 286(2):909-18. PubMed ID: 21071451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reciprocal regulation of LOX and LOXL2 expression during cell adhesion and terminal differentiation in epidermal keratinocytes.
    Fujimoto E; Tajima S
    J Dermatol Sci; 2009 Aug; 55(2):91-8. PubMed ID: 19394199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of Aqueous Humor Lysyl Oxidase Activity with TGF-ß Levels and LOXL1 Genotype in Pseudoexfoliation.
    Gayathri R; Coral K; Sharmila F; Sripriya S; Sripriya K; Manish P; Shantha B; Ronnie G; Vijaya L; Narayanasamy A
    Curr Eye Res; 2016 Oct; 41(10):1331-1338. PubMed ID: 27116380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human lysyl oxidase-like 2.
    Moon HJ; Finney J; Ronnebaum T; Mure M
    Bioorg Chem; 2014 Dec; 57():231-241. PubMed ID: 25146937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysyl oxidase-like 2 is a regulator of angiogenesis through modulation of endothelial-to-mesenchymal transition.
    de Jong OG; van der Waals LM; Kools FRW; Verhaar MC; van Balkom BWM
    J Cell Physiol; 2019 Jul; 234(7):10260-10269. PubMed ID: 30387148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The serum level and significance of lysyl oxidase-like 2 in patients with rheumatoid arthritis-associated interstitial lung disease.
    Fu Q; Bai Y; Liu Y; Zhou J; Zheng Y
    Clin Rheumatol; 2018 Jan; 37(1):193-198. PubMed ID: 29052023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Expression of the Matrix-Modifying Enzyme Lysyl Oxidase-Like 2 in Aggressive Hepatocellular Carcinoma with Poor Prognosis.
    Choi J; Chung T; Rhee H; Kim YJ; Jeon Y; Yoo JE; Noh S; Han DH; Park YN
    Gut Liver; 2019 Jan; 13(1):83-92. PubMed ID: 29938458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LOXL2 Inhibitor Attenuates Angiotensin II-Induced Atrial Fibrosis and Vulnerability to Atrial Fibrillation through Inhibition of Transforming Growth Factor Beta-1 Smad2/3 Pathway.
    Wu Y; Can J; Hao S; Qiang X; Ning Z
    Cerebrovasc Dis; 2022; 51(2):188-198. PubMed ID: 34515064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysyl oxidase-like 2 is critical to tumor microenvironment and metastatic niche formation in hepatocellular carcinoma.
    Wong CC; Tse AP; Huang YP; Zhu YT; Chiu DK; Lai RK; Au SL; Kai AK; Lee JM; Wei LL; Tsang FH; Lo RC; Shi J; Zheng YP; Wong CM; Ng IO
    Hepatology; 2014 Nov; 60(5):1645-58. PubMed ID: 25048396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Implications of Lysyl Oxidase-Like Protein 2 Expression in Pancreatic Cancer.
    Tanaka N; Yamada S; Sonohara F; Suenaga M; Hayashi M; Takami H; Niwa Y; Hattori N; Iwata N; Kanda M; Tanaka C; Kobayashi D; Nakayama G; Koike M; Fujiwara M; Fujii T; Kodera Y
    Sci Rep; 2018 Jun; 8(1):9846. PubMed ID: 29959362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysyl Oxidase-like 2 Dysregulation Increases the Risk of Post-Operative Fibrotic Scars Formation in the Female Reproductive Tract: A Novel Therapeutic Target to Reduce Fibrogenesis.
    Khodashahi R; Dehkordi S; Ahmadzade AM; Ferns GA; Aliakbarian M; Arjmand MH
    Curr Med Chem; 2024 Jun; ():. PubMed ID: 38939993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LOXL2, a copper-dependent monoamine oxidase, activates lung fibroblasts through the TGF-β/Smad pathway.
    Wen X; Liu Y; Bai Y; Li M; Fu Q; Zheng Y
    Int J Mol Med; 2018 Dec; 42(6):3530-3541. PubMed ID: 30320382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysyl oxidase like-2 contributes to renal fibrosis in Col4α3/Alport mice.
    Cosgrove D; Dufek B; Meehan DT; Delimont D; Hartnett M; Samuelson G; Gratton MA; Phillips G; MacKenna DA; Bain G
    Kidney Int; 2018 Aug; 94(2):303-314. PubMed ID: 29759420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein-2.
    Vadasz Z; Kessler O; Akiri G; Gengrinovitch S; Kagan HM; Baruch Y; Izhak OB; Neufeld G
    J Hepatol; 2005 Sep; 43(3):499-507. PubMed ID: 16023247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.